Igounenc N

Univ. Montpellier, Department of Addiction, CHU Nîmes, Nîmes, France; CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.

1 preprint · 2 papers

PreprintPsilocybin

Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial

Bukowski H, de Timary P, Belahda D +4

Europe PMC2026
ArticlePsilocybin

Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.

Garcia Garcia M, Belahda D, Graux C +5

Europe PMC2026
ArticlePsilocybin

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.

Luquiens A, Belahda D, Graux C +5

Europe PMC2025